Construction of recombinant aroA salmonellae stably producing the Shigella dysenteriae serotype 1 O-antigen and structural characterization of the Salmonella/Shigella hybrid LPS

Microbial Pathogenesis

Volumn 20, Issue 1, 1996, Pages 11-30

  Fält, Inger C ^b   Mills, Dawn ^a   Schweda, Elke K H ^c   Timmis, Kenneth N ^c   Lindberg, Alf A ^c  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c NONE

Author keywords

hybrids; LPS; Salmonella; Shigella dystenteriae type 1; vaccine

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; O ANTIGEN; SHIGELLA VACCINE;

ARTICLE; BACTERIUM MUTANT; CONTROLLED STUDY; GENETIC RECOMBINATION; IMMUNOCHEMISTRY; IMMUNOFLUORESCENCE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; SHIGELLA DYSENTERIAE; TRANSPOSON;

BACTERIA (MICROORGANISMS); SALMONELLA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR DUBLIN; SALMONELLA TYPHIMURIUM; SHIGELLA; SHIGELLA DYSENTERIAE; TYPHIMURIUM;

EID: 0343832236     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1006/mpat.1996.0002     Document Type: Article

References (44)

1. Katz SL. Diseases of importance in developing countries. In: New vaccine development, vol. II. Washington DC: National Academy of Sciences Press, 1986; 329-37.
2. Formal SN, LaBrec EH, Palmer A, Falkow S. Protection of monkeys against experimental shigellosis with attenuated vaccines. J Bacteriol 1965; 90: 63-8.
3. Levine MM, Woodward WE, Formal SB et al. Studies with a new generations of oral attenuated Shigella vaccine: Escherihia coli bearing surface antigens of Shigella flexneri. J Infect Dis 1977; 136: 577-82.
4. Kotloff KL, Herrington DA, Hale TL et al. Safety, immunogenicity and efficacy in monkeys and humans of invasive Escherichia coli K-12 hybrid vaccine candidate expressing Shigella flexneri 2a somatic antigen. Infect Immun 1992; 60: 2218-24.
5. Van de Verg L, Herrington DA, Murphy JR, Wasserman SS, Formal SB, Levine MM. Specific immunoglobulin A-secreting cells in peripheral blood of humans following oral immunization with bivalent Salmonella typhi-Shigella sonnei vaccine or infection by pathogenic S. sonnei. J Infect Immun 1990; 58: 2002-4.
6. Baron LS, Kopecko DJ, Formal SB, Seid R, Guerry P, Powell C. Introduction of Shigella flexneri 2a type and group antigen into oral typhoid vaccine strain Salmonella typhi Ty21a. Infect Immun 1987; 55: 2797-801.
7. Mills SD, Sekizaki T, Gonzalez-Carrero MI, Timmis KN. Analysis and genetic manipulation of Shigella virulence determinants for vaccine development. Vaccine 1988; 6: 116-22.
8. Stocker BAD, Hoiseth SK, Smith BP. Aromatic-dependent Salmonella sp. as live vaccine in mice and calves. Develop Biol Standard 1982; 53: 47-54.
9. Lindberg AA, Segall T, Weintraub A, Stocker BAD. Antibody response and protection against challenge in mice vaccinated intraperitoneally with a live aroA O4-O9 hybrid Salmonella dublin strain. Infect Immun 1993; 61: 1211-21.
10. Segall T, Lindberg AA. Oral vaccination of calves with an aromatic-dependent Salmonella dublin (O9, 12) hybrid expressing O4, 12 protects against S. dublin (O9, 12) but not against Salmonella typhimurium (O4, 5, 12). Infect Immun 1993; 61: 1222-31.
11. Hale TL, Guerry P, Seid JR et al. Expression of lipopolysaccharide O antigen in Escherichia coli K-12 hybrids containing plasmid and chromosomal genes from Shigella dysenteriae 1. Infect Immun 1984; 46: 470-5.
12. Watanabe H, Timmis KN. A small plasmid in Shigella dysenteriae 1 specifies one or more functions essential for O antigen production and bacterial virulence. Infect Immun 1984; 43: 391-6.
13. Watanabe H, Nakamura A, Timmis KN. Small virulence plasmid of Shigella dysenteriae 1 strain W30864 encodes a 41 000-dalton protein involved in formation of specific lipopolysaccharide side chains of serotype 1 isolates. Infect Immun 1984; 46: 55-63.
14. Sturm S, Timmis KN. Cloning of the rfb gene region of Shigella dysenteriae 1 and construction of an rfb-rfp gene cassette for the development of lipopolysaccharide-based live anti-dysentery vaccines. Microb Pathog 1986; 1: 289-97.
15. Fält IC, Schweda EKH, Weintraub A, Sturm S, Timmis KN, Lindberg AA. Expression of the Shigella dysenteriae type 1 lipopolysaccharide repeating unit in Escherichia coli K-12/Shigella dysenteriae type 1 hybrids. Eur J Biochem 1993; 213: 573-81.
16. Hashimoto-Gotoh T, Franklin FCH, Nordheim A, Timmis KN. Specific-purpose plasmid cloning vectors. I. Low copy number, temperature-sensitive, mobilization-defective, pSC101-derived containment vectors. Gene 1981; 16: 227-35.
17. Dmitriev BA, Knirel YA, Kochetkov KN, Hofman IL. Somatic antigens of Shigella. Eur J Biochem 1976; 66: 559-66.
18. Hellerqvist CG, Lindberg B, Svensson S, Holme T, Lindberg AA. Structural studies on the O-specific side chains of the cell wall lipopolysaccharides from Salmonella typhimurium 395MS. Carbohydr Res 1968; 8: 43-55.
19. Hellerqvist CG, Lindberg B, Svensson S, Holme T, Lindberg AA. Structural studies on the O-specific side chains of the cell wall lipopolysaccharides from Salmonella typhi and S. enteritidis. Acta Chem Scand 1969; 23: 1588-96.
20. 13C-nuclear magnetic resonance spectroscopy. Carbohydr Res 1984; 130: 35-53.
21. Hellerqvist CG, Lindberg AA. Structural studies of the common-core polysaccharide of the cell-wall lipopolysaccharide from Salmonella typhimurium. 1971; 16: 39-48.
22. Nikaido H. Structure of cell wall lipopolysaccharide from Salmonella typhimurium. J Biol Chem 1969; 244: 2835-45.
23. Sturm S, Jann B, Jann K, Fortnagel P, Timmis KN. Genetic and biochemical analysis of Shigella dysenteriae 1 O antigen polysaccharide biosynthesis in Escherichia coli K-12: 9kb plasmid of S. dysenteriae 1 determines addition of a galactose residue to the lipopolysaccharides core. Microb Pathog 1986; 1: 299-306.
24. Sturm S, Jann B, Jann K, Fortnagel P, Timmis KN. Genetic and biochemical analysis of Shigella dysenteriae 1 O antigen polysaccharide biosynthesis in Escherichia coli K-12: structure and functions of the rfb gene cluster. Microb Pathog 1986; 1: 307-24.
25. Fält IC, Lindberg AA. Epitope mapping of six monoclonal antibodies recognizing the Shigella dysenteriae type 1 O-antigenic repeating unit expressed in Escherichia coli K12. Microb Pathog 1994; 16: 27-41.
26. Gamian A, Romanowska E, Ulrich J, Defaye J. The structure of the sialic acid-contain ing Escherichia coli O104 O-specific polysaccharide and its linkage to the core region in lipopolysaccharide. Carbohydr Res 1992; 236: 195-208.
27. Mäkelä PH, Stocker BAD. Genetics of lipopolysaccharide. In: Rietschel ET, ed. Handbook of endotoxin. Vol. 1. Chemistry of endotoxin. Amsterdam: Elsevier, 1984: 59-137.
28. Jann K, Jann B. Structure and biosynthesis of O-antigens. In: Rietschel ET, ed. Handbook of endotoxin. Vol. 1. Chemistry of endotoxin. Amsterdam: Elsevier, 1984: 138-86.
29. Meier-Dieter U, Starman R, Barr K, Mayer H, Rich PD. Biosynthesis of enterobacterial common antigen in Escherichia coli. J Biol Chem 1990; 265: 13490-7.
30. Klena JD, Schnaitman CA. Function of the rfb gene cluster and the rfe gene in the synthesis of O antigen by Shigella dysenteriae 1. Mol Microbiol 1993; 9: 393-402.
31. Schnaitman CA, Klena JD. Genetics of lipopolysaccharide biosynthesis in enteric bacteria. Microbiol Rev 1993; 57: 655-82.
32. Subbaiah TV, Stocker BAD. Rough mutants of Salmonella typhimurium. Nature 1964; 201: 1298-9.
33. Yanisch-Perron C, Vieira J, Messing J. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 1985; 33: 103-19.
34. Walker MJ, Penserton JM. Construction of a transposon containing a gene for polygalactusonate Trans-eliminase from Klebsiella oxytoca. Anal Microbiol 1987; 146: 390-5.
35. Maniatis T, Frisch EF, Sambrook J. Molecular cloning. A laboratory manual. Cold Spring Harbor Laboratory Press, 1982.
36. Svensson SB, Lindberg AA. Immunochemistry of Salmonella O-antigens: preparation of a octasaccharide-bovine serum albumin immunogen representative of Salmonella serogroup B O-antigen and characterization of the antibody response. J Immun 1978; 120: 1750-7.
37. Weintraub A, Johnsson BN, Stocker BAD, Lindberg AA. Structural and immunochemical studies of the lipopolysaccharides of Salmonella strains with both antigen O4 and antigen O9. J Bacteriol 1992; 174: 1916-22.
38. Westphal O, Lüderitz O, Bister F, Über die Extraktion von Bakterien mit Phenol/Wasser, Z. Naturforsch 1952; 7B: 148-54.
39. Dubois M, Gilles KA, Hamilton JK, Rebers PA, Smith F. Colorimetric method for determination of sugars and related substances. Anal Chem 1955; 28: 350-6.
40. Svenungsson B, Lindberg AA. Synthetic disaccharide-protein antigens for production of specific O4 and O9 antisera for immunoflourescence diagnosis of Salmonella. Med Microbiol Immun 1977; 163: 1-11.
41. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-75.
42. Laemmli UK. Cleavage of structural protein during assembly of the head of the bacteriophage T4. Nature (London) 1970; 227: 680-5.
43. Tsai C-M, Frasch CE. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal Biochem 1982; 119: 115-9.
44. Sturm S, Fortnagel P, Timmis KN. Immunoblotting procedure for the analysis of electrophoretically-fractionated bacterial lipopolysaccharide. Arch Microbiol 1984; 140: 198-201.